Full Text View
Tabular View
No Study Results Posted
Related Studies
Screening for Barrett's Esophagus in Otolaryngology Patients (SCE)
This study is ongoing, but not recruiting participants.
Study NCT00695227   Information provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
First Received: June 6, 2008   Last Updated: March 4, 2009   History of Changes

June 6, 2008
March 4, 2009
May 2004
November 2008   (final data collection date for primary outcome measure)
The primary aim of the study is to establish that patients with symptoms of LPR who are referred to an otolaryngology clinic have a prevalence of Barrett's metaplasia equivalent to that of a population with GERD symptoms. [ Time Frame: One time ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00695227 on ClinicalTrials.gov Archive Site
 
 
 
Screening for Barrett's Esophagus in Otolaryngology Patients
Screening for Barrett's Esophagus in Otolaryngology Patients

The purpose of this project is to develop an accurate method to identify patients that suffer from acid reflux, but may not present with classic reflux symptoms (such as heart burn). Additionally, it is the purpose of this project to utilize the Unsedated Small-caliber Endoscopy (USE) to assess the prevalence of Barrett's esophagus in a population of patients with laryngopharyngeal reflux (LPR) symptoms and to define normal patterns of LPR. Laryngopharyngeal reflux (LPR) is when a small amount of stomach contents and acid are pushed up through the esophagus and may affect the vocal cords and upper respiratory tract.

It is suspected that patients with LPR symptoms may have a prevalence of Barrett's esophagus similar to that found in a population with typical reflux symptoms. We propose to systematically test this hypothesis using the USE.

This project is designed to improve the methods of identifying patients with a form of acid reflux that is often undetected, and thus untreated. If this project is successful then more patients with Barrett's esophagus will be identified; furthermore, screening and treatment for this pre-cancerous condition will be improved.

 
Phase II
Interventional
Treatment, Non-Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
  • Extra Esophageal Symptoms:
  • Cough
  • Throat Clearing
  • Hoarseness
  • Difficulty Swallowing
Drug: Proton Pump Inhibitor
 
 

*   Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
 
Active, not recruiting
500
November 2012
November 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

-

Exclusion Criteria:

  • Prior anti-reflux surgery, laryngeal surgery, trauma to larynx Esophageal diverticulum Pregnancy Anticoagulation therapy Esophageal varices ENT malignancy History of recurrent epistaxis
Both
18 Years to 90 Years
Yes
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00695227
Joshua Schindler, Oregon Health & Science University
DK66165, DK066165-02
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
 
Principal Investigator: Joshua Schindler, MD Oregon Health and Science University
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
March 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP